Novavax Reports First Quarter 2022 Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Novavax (NVAX) Misses Q1 EPS by 13c; Offers FY22 Revenue Guidance
May 9, 2022 4:03 PM EDTNovavax (NASDAQ: NVAX) reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million.
GUIDANCE:
Novavax sees FY2022 revenue of $4-5 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
... More